The FDA recently published three separate Class II recalls related to insulin pump systems made by MiniMed (Nasdaq:MMED).

Insulet announced on social media today that it appointed a new SVP, chief quality, regulatory and compliance officer.

ViCentra told customers that it expects no immediate impact from Dexcom's planned discontinuation of the G6 CGM line.

The Germantown, Maryland-based company launched Eversense 365, its implantable CGM in 2024. Eversense 365 rests under the ...

Vivani Medical (Nasdaq:VANI) announced the successful completion of the first-in-human study of its GLP-1 implant.

Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

Novo Nordisk announced today that it received FDA approval for Awiqli, the first and only once-weekly, long-acting basal ...

An Irish construction company said on LinkedIn that it completed work on a Dexcom (Nasdaq:DXCM) facility in Athenry, Ireland.

BTIG analysts today opened coverage for MiniMed (Nasdaq:MMED) with optimism about the company's scale, reach and potential ...

Abbott (NYSE:ABT) today said it launched a new bundle with Withings for its Lingo over-the-counter glucose biosensor.

Beta Bionics (Nasdaq:BBNX) announced today that it launched Bionic Insights, a new feature for healthcare providers and ...

BD (NYSE:BDX) announced today that it launched its Pyxis Pro Dispensing Solution and Incada Connected Care Platform in Europe ...